Immuron Ltd (IMRN)
2.63
+0.20
(+8.23%)
USD |
NASDAQ |
Apr 26, 13:47
Immuron Total Liabilities (Quarterly): 1.605M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.605M |
| December 31, 2023 | 1.605M |
| June 30, 2023 | 1.570M |
| December 31, 2022 | 1.249M |
| December 31, 2022 | 1.249M |
| June 30, 2022 | 1.155M |
| December 31, 2021 | 0.8696M |
| December 31, 2021 | 0.8696M |
| June 30, 2021 | 0.8701M |
| December 31, 2020 | 0.4022M |
| December 31, 2020 | 0.4022M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.3836M |
| December 31, 2019 | 1.065M |
| December 31, 2019 | 1.065M |
| June 30, 2019 | 0.8478M |
| December 31, 2018 | 0.3672M |
| December 31, 2018 | 0.3672M |
| June 30, 2018 | 0.5901M |
| December 31, 2017 | 0.9156M |
| December 31, 2017 | 0.9156M |
| June 30, 2017 | 1.315M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.3836M
Minimum
Jun 2020
1.605M
Maximum
Dec 2023
1.014M
Average
1.065M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| Mesoblast Ltd | 167.58M |
| CERo Therapeutics Holdings Inc | -- |
| Alterity Therapeutics Ltd | 2.345M |
| Kazia Therapeutics Ltd | 10.61M |
| Immutep Ltd | 9.137M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.55M |
| Shareholders Equity (Quarterly) | 11.94M |
| Current Ratio | 8.519 |